99 related articles for article (PubMed ID: 9454106)
1. [Significance, pathomechanism and prevention of risk factors in first-dose-hypotension in the therapeutic use of ACE inhibitors].
Moser G; Együd F
Orv Hetil; 1998 Jan; 139(1):17-21. PubMed ID: 9454106
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
3. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
4. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
[TBL] [Abstract][Full Text] [Related]
5. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
6. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
Navookarasu NT; Rahman AR; Abdullah I
Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
[TBL] [Abstract][Full Text] [Related]
7. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
Sami M
Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
[TBL] [Abstract][Full Text] [Related]
9. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
10. [Remodeling with angiotensin-converting enzyme inhibitors: from GISSI to PREAMI].
Nicolosi GL
Ital Heart J; 2005 Nov; 6 Suppl 7():33S-39S. PubMed ID: 16485515
[TBL] [Abstract][Full Text] [Related]
11. [Hypotension followed the first dose of angiotensin-converting enzyme inhibitor in patients with heart failure (a multicenter clinical trial)].
Moiseev VS; Tereshchenko SN; Aleksandriia LG; Kobalava ZhD
Ter Arkh; 2001; 73(9):61-6. PubMed ID: 11642085
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
Thanikachalam S; Manchanda SC
Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
[TBL] [Abstract][Full Text] [Related]
13. The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose-comparison study.
Shahzamani M; Yousefi Z; Frootaghe AN; Jafarimehr E; Froughi M; Tofighi F; Azadani AN; Pourhoseingholi MA; Azadani PN
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):185-91. PubMed ID: 19721131
[TBL] [Abstract][Full Text] [Related]
14. [The hypotension risk during the therapy of heart failure with ACE inhibitors].
Osterziel KJ; Dietz R
Dtsch Med Wochenschr; 1993 Jan; 118(3):65-8. PubMed ID: 8425460
[No Abstract] [Full Text] [Related]
15. The effect of early perindopril administration on mortality and morbidity in patients with high risk of acute myocardial infarction.
Protopopescu T; Toporan D; Paraschiv A; Ioan A
Rom J Intern Med; 1998; 36(3-4):197-205. PubMed ID: 10822516
[TBL] [Abstract][Full Text] [Related]
16. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
[TBL] [Abstract][Full Text] [Related]
17. Adverse event with first-dose perindopril in congestive heart failure.
Bagger JP
Lancet; 1997 Jun; 349(9066):1671-2. PubMed ID: 9186393
[No Abstract] [Full Text] [Related]
18. [How should ACE inhibitors be used in myocardial infarction?].
Reikvam A; Madsen S
Tidsskr Nor Laegeforen; 2000 Nov; 120(28):3413-7. PubMed ID: 11187196
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
Brugts JJ; Ferrari R; Simoons ML
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
[TBL] [Abstract][Full Text] [Related]
20. [Change of circadian pattern of arterial pressure in patients with congestive heart failure treated with perindopril, an inhibitor of angiotensin-converting enzyme (ACE)].
Tereshchenko SN; Kobalova ZhD; Demidova IV; Moiseev VS
Ter Arkh; 1997; 69(12):40-3. PubMed ID: 9503533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
